Literature DB >> 10614867

Evaluation of an in vitro coculture model for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources.

J L Scism1, D A Laska, J W Horn, J L Gimple, S E Pratt, R L Shepard, A H Dantzig, S A Wrighton.   

Abstract

Cocultures of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources, American Type Culture Collection and European Collection of Animal Cell Cultures, were evaluated as an in vitro model for the blood-brain barrier. Monolayers of endothelial cells grown in the presence or absence of glial cells were examined for transendothelial electrical resistance, sucrose permeability, morphology, multidrug resistance-associated protein expression, and P-glycoprotein expression and function. Coculture of glial cells with endothelial cells increased electrical resistance and decreased sucrose permeability across European endothelial cell monolayers, but had no effect on American endothelial cells. Coculture of European glial cells with endothelial cells caused cell flattening and decreased cell stacking with both European and American endothelial cells. No P-glycoprotein or multidrug resistance-associated protein was immunodetected in endothelial cells grown in glial cell-conditioned medium. Functional P-glycoprotein was demonstrated in American endothelial cells selected in vinblastine-containing medium over eight passages, but these cells did not form a tight endothelium. In conclusion, while European glial cells confer blood-brain barrier-like morphology and barrier integrity to European endothelial cells in coculture, the European endothelial-glial cell coculture model does not express P-glycoprotein, normally found at the blood-brain barrier. Further, the response of endothelial cells to glial factors was dependent on cell source, implying heterogeneity among cell populations. On the basis of these observations, the umbilical vein endothelial cell-glial cell coculture model does not appear to be a viable model for predicting blood-brain barrier penetration of drug molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614867     DOI: 10.1007/s11626-999-0096-3

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  33 in total

Review 1.  Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.

Authors:  B I Sikic; G A Fisher; B L Lum; J Halsey; L Beketic-Oreskovic; G Chen
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

2.  Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats.

Authors:  Q Wang; H Yang; D W Miller; W F Elmquist
Journal:  Biochem Biophys Res Commun       Date:  1995-06-26       Impact factor: 3.575

Review 3.  CNS drug design based on principles of blood-brain barrier transport.

Authors:  W M Pardridge
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

4.  Induction of gap junctions and brain endothelium-like tight junctions in cultured bovine endothelial cells: local control of cell specialization.

Authors:  R R Shivers; F E Arthur; P D Bowman
Journal:  J Submicrosc Cytol Pathol       Date:  1988-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

7.  Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model.

Authors:  B Joly; O Fardel; R Cecchelli; C Chesné; C Puozzo; A Guillouzo
Journal:  Toxicol In Vitro       Date:  1995-08       Impact factor: 3.500

8.  Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.

Authors:  F Tiberghien; F Loor
Journal:  Anticancer Drugs       Date:  1996-07       Impact factor: 2.248

9.  MDR1 gene expression in brain of patients with medically intractable epilepsy.

Authors:  D M Tishler; K I Weinberg; D R Hinton; N Barbaro; G M Annett; C Raffel
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864

10.  A cell culture model of the blood-brain barrier.

Authors:  L L Rubin; D E Hall; S Porter; K Barbu; C Cannon; H C Horner; M Janatpour; C W Liaw; K Manning; J Morales
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  6 in total

Review 1.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features.

Authors:  K Suda; B Rothen-Rutishauser; M Günthert; H Wunderli-Allenspach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

Review 3.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

4.  Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro.

Authors:  Guang-Yun Wang; Ning Wang; Hua-Ning Liao
Journal:  Cell Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.046

5.  Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids.

Authors:  Stefanie D Krämer; Yannic B Schütz; Heidi Wunderli-Allenspach; N Joan Abbott; David J Begley
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Nov-Dec       Impact factor: 2.416

6.  Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier.

Authors:  Shu Yang; Shenghui Mei; Hong Jin; Bin Zhu; Yue Tian; Jiping Huo; Xu Cui; Anchen Guo; Zhigang Zhao
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.